Home > Official notices > Statutory Committee inquiries  |  Search

The Pharmaceutical Journal
Vol 275 No 7379 p730
10 December 2005


Statutory Committee inquiries

The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 10am on Monday to Thursday, 12 to 15 December 2005, to hear the following inquiries and applications:

Monday 12 December
1. An inquiry into a complaint by the Council of the Society against Derek Michael Phillips (registration number 75766) which alleges that discrepancies in Viagra 50mg and 100mg stock, breaches of Regulation 19 of the Misuse of Drugs Regulations, breaches of the Misuse of Drugs (Safe Custody) Regulations, a failure to deal appropriately with Controlled Drugs (failure to segregate patient returns and date-expired stock), the supply of sildenafil without a valid prescription, breaches of Regulation 6 of the Medicines (Sale and Supply) (Miscellaneous Provisions) Regulations 1980 and the condition of the pharmacy, notwithstanding a warning from the Society Inspector, may amount to misconduct.

Tuesday 13 December
2. A resumed inquiry into the case of Navjot Kaur Manku (registration number 1053064), who has been convicted of two counts of possession of a Class B Controlled Drug; two counts of possession of a Class C Controlled Drug; and two counts of theft.

Wednesday 14 December
3. An inquiry into the case of Harwinder Singh Doal (registration number 3000717), who has been convicted of: using or threatening unlawful violence towards another, contrary to Section 3(1) of the Public Order Act 1968; criminal damage; possession of an offensive weapon, contrary to Section 1(1) of the Prevention of Crime Act 1953; affray; religiously aggravated common assault; breach of a community punishment order; and driving with excess alcohol.

Thursday 15 December
4. An inquiry into a complaint by the Council of the Society against John Joseph George Barnes (registration number 62087), which alleges that a dispensing error, a failure to contact the prescriber for clarification, the dismissive response to the error, a failure to keep an accurate record in the patient medication record and a failure to record the error may amount to misconduct.

David Gomez
Secretary to the Statutory Committee

Back to Top


©The Pharmaceutical Journal